Diagnóstico y tratamiento | 22 MAR 22

Anomalías pigmentarias congénitas en el neonato

Actualización sobre manifestaciones, diagnóstico y tratamiento de las anomalías pigmentarias congénitas neonatales.
Autor/a: Kaiane A. Habeshian, A. Yasmine Kirkorian NeoReviews 2021;22;e660
INDICE:  1. Texto principal | 2. Referencia bibliográfica
Referencia bibliográfica

1. Salas-Labadıa C, Gomez-Carmona S, Cruz-Alcıvar R, et al. Genetic and clinical MCL characterization of 73 Pigmentary Mosaicism patients: revealing the genetic basis of clinical MCL manifestations. Orphanet J Rare Dis. 2019;14(1):259

2. Chamli A, Litaiem N. Hypomelanosis of Ito. StatPearls [Internet]. Last update June 27, 2020 https://www.ncbi.nlm.nih.gov/books/NBK538268/

3. Dobyns WB, Mirzaa GM. Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR. Am J Med Genet C Semin Med Genet. 2019;181(4):582–590

4. Taylor DL, Wildin RS, Morley KW. Novel neonatal presentation of megalencephaly-polymicrogyria-pigmentary mosaicism syndrome (MPPM) related to MTOR mutation: report of a case. Pediatr Dermatol. 2020; 38(2):536–537. doi: 10.1111/pde.14480

5. Asch S, Sugarman JL. Epidermal nevus syndromes: new insights into whorls and swirls. Pediatr Dermatol. 2018;35(1):21–29

6.Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol. 1979;1(2):123–130

7. Price HN, Schaffer JV. Congenital melanocytic nevi-when to worry and how to treat: facts and controversies. Clin Dermatol. 2010;28(3):293–302

8. Price HN, O’Haver J, Marghoob A, Badger K, Etchevers H, Krengel S. PractiMCL application of the new classification scheme for congenital melanocytic nevi. Pediatr Dermatol. 2015;32(1):23–27

9.Castilla EE, da Gra¸ca Dutra M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi: I, incidence rates and relative frequencies. Br J Dermatol. 1981;104(3):307–315

10. Kinsler VA, Thomas AC, Ishida M, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. [published correction appears in J Invest Dermatol. 2016;136(11):2326] J Invest Dermatol. 2013;133(9):2229–2236

11. Polubothu S, McGuire N, Al-Olabi L, et al. Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi. Br J Dermatol. 2020;182(2):434–443

12. Mir A, Agim NG, Kane AA, Josephs SC, Park JY, Ludwig K. Giant congenital melanocytic nevus treated with trametinib. Pediatrics. 2019;143(3):e20182469

13. Kinsler VA, O’Hare P, Jacques T, Hargrave D, Slater O. MEK inhibition appears to improve symptom control in primary NRAS driven CNS melanoma in children. Br J Cancer. 2017;116(8):990–993

14. Margileth AM. Spontaneous regression of large congenital melanocytic nevi, with a halo rim in 17 children with large sMCLp and trunk nevi during 45 years: a review of the literature. Clin Pediatr (Phila). 2019;58(3):313–319

15. Kittler NW, Mathes EF, Kinsler V, Frieden IJ. The biker-glove pattern of congenital melanocytic nevi. Pediatr Dermatol. 2019;36(6):918–921

16. Kinsler VA, Larue L. The patterns of birthmarks suggest a novel population of melanocyte precursors arising around the time of gastrulation. Pigment Cell Melanoma Res. 2018;31(1):95–109

17. Kinsler V, Shaw AC, Merks JH, Hennekam RC. The face in congenital melanocytic nevus syndrome. Am J Med Genet A. 2012;158A(5):1014–1019

18. Kinsler VA, O’Hare P, Bulstrode N, et al. Melanoma in congenital melanocytic naevi. Br J Dermatol. 2017;176(5):1131–1143

19. Hawryluk EB, Moustafa D, Bartenstein D, et al. A retrospective multicenter study of fatal pediatric melanoma. J Am Acad Dermatol. 2020;83(5):1274–1281

20. Kinsler V, Bulstrode N. The role of surgery in the management of congenital melanocytic naevi in children: a perspective from Great Ormond Street Hospital. J Plast Reconstr Aesthet Surg. 2009;62(5):595–601

21. Greywal T, Matiz C. Speckled lentiginous nevus: A rare presentation associated with motor neuropathy and muscular atrophy in a child. Pediatr Dermatol. 2018;35(3):e161–e162

22. Schaffer JV, Orlow SJ, Lazova R, Bolognia JL. Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. Arch Dermatol. 2001;137(2):172–178

23. Brito MH, Dionısio CS, Fernandes CM, Ferreira JC, Rosa MJ, Garcia MM. Synchronous melanomas arising within nevus spilus. An Bras Dermatol. 2017;92(1):107–109

24. Sarin KY, McNiff JM, Kwok S, Kim J, Khavari PA. Activating HRAS mutation in nevus spilus. J Invest Dermatol. 2014;134(6):1766–1768

25. Torchia D, Happle R. Papular nevus spilus syndrome: old and new aspects of a mosaic RASopathy. Eur J Dermatol. 2019;29(1):2–5

26. Lalor L, Davies OMT, Basel D, Siegel DH. Cafe au lait spots: when and how to pursue their genetic origins. Clin Dermatol. 2020;38(4):421–431

27. St John J, Summe H, Csikesz C, Wiss K, Hay B, Belazarian L. Multiple cafe au lait spots in a group of fair-skinned children without signs or symptoms of neurofibromatosis type 1. Pediatr Dermatol. 2016;33(5):526–529

28. DeBella K, Szudek J, Friedman JM. Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105(3 Pt 1):608–614

29. Evans DGR, Salvador H, Chang VY, et al. Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res. 2017;23(12):e46–e53. doi: 10.1158/1078-0432. CCR-17-0589



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022